Pennsylvania Medical Marijuana Advisory Board Rejects Insomnia as New Qualifying Condition
Atomazul | Adobe Stock

Pennsylvania Medical Marijuana Advisory Board Rejects Insomnia as New Qualifying Condition

Regulators also tabled a discussion on whether to add traumatic brain injuries to the list.

Subscribe
November 12, 2020

The Pennsylvania Medical Marijuana Advisory Board held a quarterly meeting Nov. 10, where it rejected adding insomnia to the state’s list of qualifying conditions, according to a TribLive.com report.

The board voted 7-4 to reject insomnia as a new qualifying condition, and tabled a discussion on whether to add traumatic brain injuries to the list, the news outlet reported.

There are more than 460,000 Pennsylvanians currently enrolled in the state’s medical cannabis program, according to TribLive.com, and while there are currently 23 qualifying conditions, the vast majority of patients qualify under anxiety disorders, chronic pain and post-traumatic stress disorder (PTSD).

The public can apply for new conditions to be added to the list, and the Medical Marijuana Advisory Board considers the applications and makes recommendations, although Pennsylvania Health Secretary Rachel Levine makes the final decision on which conditions make the list, TribLive.com reported.